Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT20 in Hyperphosphataemia and Dialysis Dependent CKD
NCT02151643Phase 2Completed
- Sponsor
- Phosphate Therapeutics
- Start
- May 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Iron (III) oxide adipate in hyperphosphatemia, sponsored by Phosphate Therapeutics. Started May 2014; status: completed.
02
Drugs
Iron (III) oxide adipate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT02151643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151643.